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International Centre for Eye Health, 
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Medicine. His field research, conducted 
in Bauchi, is aimed at understanding how 
people’s awareness of glaucoma relates 
to the severity of glaucoma they have 
when they arrive at the hospital as well as 
their ability to manage the disease. He 
spoke to Fatima Kyari.
in general, how advanced is the 
glaucoma in patients presenting at 
your hospital?
Most of our patients present with 
advanced disease. The usual presen-
tation is with one eye blind and the other 
with moderately advanced disease. We 
think this is because they are not aware of 
glaucoma and do not understand how 
important it is to seek help.
How did you find out what people 
thought about glaucoma? 
We met with a number of patients’ relatives 
and traditional healers and conducted a 
series of interviews and focus group 
discussions. The term ‘glaucoma’ was not 
known by many people. Those who had 
heard the term had different ideas about 
what it meant. There is no local word for 
the disease. Some knew it as ‘black 
blindness’, as opposed to ‘white 
blindness’ (cataract).
Different people had different ideas 
about the causes of glaucoma. Some 
thought it was caused by excessive crying, 
excessive anger, or excessive exposure to 
firewood smoke. Others related it to black 
flies or confused it with river blindness. 
Some understood it as hypertension of 
the eye. Very few people related it to 
death of the nerve of the eye.
What prevents people from coming 
forward early enough?
The main reason is the lack of symptoms. 
This, together with poor awareness of 
the existence of the disease, means 
that people wait until the eye is blind or 
there is substantial loss of vision before 
they come. 
Also, people in this area know about 
cataract and tend to wait until the 
cataract is mature before they come for 
an operation. So those experiencing 
some sight loss often assume they have 
cataract and by the time they come it is 
too late to save their sight. 
People also waste a lot of time seeking 
alternative or traditional medication. This 
is because, in many communities, tradi-
tional healers are more easily available 
and accessible. They come to the 
patient’s house and offer their services, 
which the patient is often unable to refuse 
because the healers are recommended 
by influential relatives and they may 
initially offer free service or service 
on credit. 
Treatment provided by traditional 
healers can sometimes cause physical 
harm, but perhaps the most serious 
consequence is that this will cause a 
delay in patients seeking and receiving 
the correct medical treatment. The 
consequence of this delay is very often 
frustration for the health worker, grief for 
the family, and irreversible blindness for 
the patient.
How can we encourage people to 
come forward early enough?
I think the key to getting patients to 
treatment sooner is to create awareness, 
emphasising the lack of initial symptoms 
and urging the people most at risk to go 
for a check-up. These are people with first 
degree relatives with blindness or 
glaucoma, people wearing glasses for 
myopia, those on long-term steroid 
treatment, and all adults over 40 years 
with diabetes, hypertension, or a history 
of trauma to the eye. 
Radio and television can make a big 
difference. Every time we talk about any 
disease on TV or radio, our clinics are full of 
people the next day who either think they 
have the condition or want to be screened 
for it. So these kinds of programmes, done 
often enough, will reach more and more 
people in the community and will reduce 
the level of ignorance about the disease 
in the community.
What form of treatment is most suitable 
in your area: medication or surgery?
The cost of eye drops is a major barrier 
against adherence to treatment in our 
patients. The cost of one month’s 
treatment with the more effective drugs is 
more than the minimum wage in the 
country. Although there are cheaper 
generic medications on the market, they 
are not really available here. 
We tend to recommend surgery as it is 
a single procedure. When successful, it 
maintains the pressure for a long time. 
However, surgery has its problems too, as 
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Gender and glaucoma
the rate of failure of the fi lter is high in 
African patients and therefore regular 
follow-up is important. Another problem is 
that some doctors are reluctant to 
operate on patients if they have advanced 
glaucoma because of the risk of wiping 
out the remaining vision. If a patient does 
lose their vision after surgery, she or he 
may attribute that to the surgery, not the 
severity of the disease. Cases like these 
may give a clinic and the doctor a bad 
reputation and drive away patients.
Laser treatment is a good option where 
available. It is non-invasive, affords 
reasonable control over a long period of 
time, and can be repeated. Lately we 
have been offering diode laser cyclo-
photo-ablation – one of the various laser 
procedures available for glaucoma – and 
our patients are accepting this more and 
more as an alternative to surgery and eye 
drops. The outcome of treatment has 
been good so far in the group of patients 
we are following.
How difficult is it to 
ensure that people 
come for treatment 
and follow-up? 
Distance to glaucoma 
clinics is one of the 
reasons that stops 
patients coming to 
hospital. One way to 
remove this barrier would 
be to establish outreach 
clinics in communities, 
staffed by nurses and allied eye care 
personnel able to recognise glaucoma 
and refer patients. 
When we investigated why some 
people did not come for follow-up visits, 
many patients we spoke to said they
were put off by the unsympathetic 
attitudes of health care workers. They 
also complained about the long waiting 
times before being seen, clinic workers’ 
inability to retrieve their records, and 
queue-jumping by some patients. 
How can we improve patients’ 
experience?
We must ensure that clinics are organised 
and that we treat patients on a strictly 
first-come, first-served basis. We must 
improve our record-keeping and filing 
systems, and reduce waiting times (see 
Community Eye Health Journal Issue 78: 
‘Putting patients at the centre of eye care’ 
and Community Eye Health Journal Issue 
74: ‘Ten years to VISION 2020: Why infor-
mation matters’).
Our communication with patients must 
also improve. Many patients come to the 
hospital and receive treatment without 
knowing what they are being treated for. 
Health workers must explain patients’ 
diagnoses to them, say what glaucoma is 
all about, how it will 
impact on their sight and 
life, and discuss the 
management options 
with the patients
(see page 54).
Other factors that are 
barriers to treatment – 
such as the availability of 
facilities and drugs for 
treatment, the distance 
to such facilities, and 
availability and cost of 
drugs – must also be addressed.
For those who are able to afford eye 
drops, what are the challenges?
Patients sometimes stop using their eye 
drops because there is usually no 
improvement in vision and no relief of 
symptoms (as they had no other 
symptoms to start with). Therefore, there 
is little to motivate them to persist with 
their treatment. Continuing deterioration 
in vision is an issue even in patients who 
continue to use their medication as 
prescribed. When this happens, patients 
feel that their treatment has failed and 
they visit traditional healers instead of 
coming back to the clinic to find out about 
alternatives, such as surgery.
Traditional healers are often allowed 
to advertise on television and on local 
radio, and actively encourage patients to 
stop treatment. By the time patients 
come back to us, they are irreversibly 
blind, with no light perception, after 
having tried and lost faith in the tradi-
tional healers. They come back to us 
broke, despondent, and desperate for 
anything to restore their sight. 
 
What can eye care practitioners do
to help? 
To ensure patients continue with their 
treatment, we must ensure that they 
know the following: 
1 Their vision may not improve even 
when the treatment is effective.
2 There may be slight deterioration in 
their vision over time even when on 
medication as the treatment is not a 
cure but a control to delay blindness for 
as long as possible. 
3 Patients should continue with their 
treatment even if the eye is completely 
blind. Doing so will prevent them from 
having a painful blind eye or a discol-
oured eye from corneal decompensation.
It is important to use strategies that 
motivate, empower, and commit the 
patient to change their behavior and 
improve their control of the glaucoma.
We are exploring the use of motivational 
interviewing, administered by trained 
counsellors, to achieve this.
Evidence suggests that women account 
for about:
•	55% of people with open-angle 
glaucoma 
•	70% of people with angle-closure 
glaucoma.
There are very few studies on service 
provision. 
•	In Tanzania, women account for a 
smaller proportion of people receiving 
surgical intervention for glaucoma.
•	In Malawi, women who are suspected of 
having glaucoma are less likely to be 
referred to secondary facilities for 
assessment.
What	can	we	do?
•	Hospitals should be monitoring the use 
of medical and surgical services by for 
men and women separately. If you note 
more men receiving services than 
women, you should investigate.
•	Screening programmes are rare; where 
they exist, findings for men and women 
should be assessed separately. Use the 
findings to revise the programme.
•	Qualitative research is needed in a 
number of settings to understand any 
differences in how men and women with 
glaucoma seek help, whether medical 
or surgical. Use this information to 
develop gender-specific educational 
materials and programmes.
•	In many settings, coming to hospital or 
clinic is difficult for women. Programmes 
should aim to create a more dynamic 
network to enable follow-up.
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‘Health workers 
must explain 
patients’ diagnosis 
to them, say
what glaucoma
is all about’
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